The recommended dose of Reconcile is
1-2 mg/kg of body weight, given once daily. Follow your veterinarian's
- Offer Reconcile to dogs
with or without food.
- Give one 8 mg tablet to
dogs weighing 8.8 to 17.6 lbs.
- Give one 16 mg tablet to
dogs weighing 17.7 to 35.2 lbs.
- Give one 32 mg tablet to
dogs weighing 35.3 to 70.4 lbs.
- Give one 64 mg tablet to
dogs weighing 70.5 to 140.8 lbs.
- If a dose is missed, wait
until the next scheduled dose. Do not double up on doses or increases
the dosage amount.
Frequency of Use:
Administer Reconcile once daily for
8 weeks, or as instructed by your veterinarian. The effectiveness and
safety of using Reconcile longer than 8 weeks is not known.
Store between 66 and 77 degrees F.
Leave desiccant inside the bottle, and completely close the bottle between
It is a violation of Federal Law
to use this product in a manner inconsistent with its labeling.
The active ingredient in Reconcile,
fluoxetine hydrochloride, is a selective serotonin reuptake inhibitor,
or SSRI. This medication works by inhibiting the reuptake of serotonin,
a neurotransmitter, at the pre-synaptic neuron. Fluoxetine does not
work by sedation.
Keep this product out of reach of children
and animals. Do not use or store in or near open flame or heat.
Not for use in humans.
Reconcile is contraindicated for use
in dogs with a history of seizures or epilepsy. Do not give this medication
to dogs taking medications that lower the seizure threshold.
Reconcile is intended for dogs age
6 months and older that weigh a minimum of 8.8 lbs. Not for use in cats
or other animals.
CAUTION: Do not use Reconcile
in combination with monoamine oxidase inhibitor medications. Wait a
minimum of 14 days after stopping MAOI therapy before starting treatment
with Reconcile. Wait 6 weeks after stopping Reconcile before starting
treatment with any medication that may interact with norfluoxetine or
Do not give this medication to dogs
with a known sensitivity to fluoxetine HCl or any other SSRI drug.
It is not know what effects Reconcile
has on pregnant, lactating, or breeding dogs. Do not give this medication
to puppies less than 6 months old.
It is not know what adverse effects
may result in dogs taking Reconcile and medications that affect the
cytochrome P450 enzyme system.
Seek veterinary attention immediately
for known or suspected overdose.
Adverse effects include possible seizures
and weight loss. Other adverse effects may include lethargy, depression,
vomiting, restlessness, diarrhea, aggression, shaking, appetite loss,
whining, and other side effects.
Inform your veterinarian if your dog
is currently using Anipryl, Mitaban Dip, or a Preventic Collar. Tell
your veterinarian of any other medications your pet is taking or has
Warranty and Manufacturer Information:
NADA #141-272, Approved by FDA
Manufactured for: Elanco Animal Health,
A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis,
Please visit the website www.reconcile.com
Reconcile® is a registered trademark
of Eli Lilly and Company.
NAC No.: 10310440